Ossium Health

After we reported the first transplant with Ossium’s organ donor bone marrow, several news outlets published stories on this milestone and what it means for the future of stem cell accessibility. We’ve compiled them here ??

Check out WIRED’s coverage of the recent transplants with Ossium’s organ donor bone marrow, an informative piece by Emily Mullin on the need for new stem cell donor options and the enormous potential for Ossium’s technology to fill critical gaps and save lives.

Today’s edition of Forbes’ emerging science and technology newsletter, The Prototype, covers how Ossium is “extending a lifeline to leukemia patients” by providing a new source of bone marrow for stem cell transplants.

??? Gift of Life Michigan's President and CEO, Dorrie Dils, recently joined WKZO Kalamazoo Mornings to share an exciting breakthrough! A Flint woman battling leukemia became the world's first recipient of a bone marrow transplant from a deceased donor, thanks to the generosity of a Michigan organ donor and the innovative partnership between Gift of Life Michigan and Ossium Health.?? ???Check out the full interview to learn more: https://lnkd.in/gWzG22cs #DonateLife

Ossium Health is happy to share that?WDIV Local 4 News/ClickOnDetroit covered an inspiring story about a Michigan woman with leukemia who is the first in the world to successfully receive a bone marrow transplant from a deceased donor using our technology. This groundbreaking development offers a new source of stem cells for life-saving transplants. We are proud to be leading the way in making more treatment options available for patients in need. Check out the full story here:?https://lnkd.in/gC3ZUZFn #TransplantInnovation #Cryopreservation #Healthcare #CellTherapy #OssiumHealth #MedicalAdvancement

We’re proud to announce our partnership with Biomedical Advanced Research and Development Authority (BARDA) to advance our cryopreserved bone marrow product for use after a radiological or nuclear emergency. Quick access to bone marrow transplants is essential for managing radiation damage, and Ossium’s ability to store cryopreserved bone marrow units in advance could enable faster life-saving treatments for more patients. Read more about how we’re strengthening national preparedness here:? https://lnkd.in/gMif2kEH

We’re delighted to share that our next-generation viable bone matrix allograft, OssiGraft Prime?, has won the prestigious Spine Technology Award from Orthopedics This Week. This award recognizes Ossium’s contributions to spinal fusion advancements, our commitment to pushing the boundaries of innovation, and our efforts to improve patient outcomes. Read more here ?? https://lnkd.in/g4ZEhWMX

Honored to see Ossium featured among Becker's Spine Review's top 5 spine and orthopedic biologics companies to know! Check it out here: https://lnkd.in/gA4UXpHb

On this World Marrow Donor Day, we’re expressing our sincere gratitude to both living and deceased bone marrow donors and their families, who selflessly give to others to save lives. #WMDD24 #WMDD #thankyoudonor

2,850 days. Almost 8 years. That's how long it took to save a life. In August of 2016 my First Round Capital partner, Bill Trenchard, led Ossium Health's Seed round. And in May of 2024, a 68 year-old woman in Michigan became the first patient to receive a bone marrow transplant from a deceased donor. When she was not able to find a bone marrow match from a living donor, her doctor enrolled her in Ossium's PRESERVE I clinical trial -- and she matched with bone marrow stored in at Ossium's biobank (the only bone marrow biobank in the world). Until now, every time an organ donor died, their bone marrow was discarded. Thrown away. Even if there was a cancer patient who was a genetic match and desperately needed that bone marrow -- it was just thrown away. Ossium figured out how to collect, process and cryopreserve bone marrow from deceased organ donors. Their network of 27 organ procurement organizations recovers bone marrow from organ donors and transports it to Ossium's facility where the company processes and manufactures the doses for the patients -- and cryopreserves it in their biobank. Before Ossium it typically took months to find a living bone marrow donor who is: a) a genetic match, b) healthy enough, and c) willing to donate. And those are months that a blood cancer patient often doesn't have. Today there is a woman in Michigan who is alive -- and on a great recovery trajectory from her blood cancer -- because Ossium had bone marrow sitting in a freezer that could match her and save her life. Congrats to Kevin Caldwell and the entire Ossium team. We can't wait to see the impact you have over the next 2,850 days. Read the news story here: https://lnkd.in/drMP3snS